Publications en collaboration avec des chercheurs de Hospital General de Ciudad Real (24)

2022

  1. Guidelines on the management of mineral and bone metabolism disorders during pregnancy and lactation

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 7, pp. 530-539

2020

  1. Phosphate disorders and clinical management of hypophosphatemia and hyperphosphatemia

    Endocrinologia, Diabetes y Nutricion, Vol. 67, Núm. 3, pp. 205-215

2018

  1. Circulating levels of sclerostin are associated with cardiovascular mortality

    PLoS ONE, Vol. 13, Núm. 6

2017

  1. Recommendations on the effect of antidiabetic drugs in bone

    Endocrinologia, Diabetes y Nutricion, Vol. 64, pp. 1-6

  2. Recommended vitamin D levels in the general population

    Endocrinologia, Diabetes y Nutricion, Vol. 64, pp. 7-14

2016

  1. Metabolomic profile related to cardiovascular disease in patients with type 2 diabetes mellitus: A pilot study

    Talanta, Vol. 148, pp. 135-143

  2. Relationship between myostatin and irisin in type 2 diabetes mellitus: a compensatory mechanism to an unfavourable metabolic state?

    Endocrine, Vol. 52, Núm. 1, pp. 54-62

  3. Serum dickkopf1 (DKK1), bone metabolism and atherosclerotic disease in patients with type 2 diabetes

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 8, Núm. 1, pp. 24-29

2015

  1. Relationship between proinflammatory and antioxidant proteins with the severity of cardiovascular disease in type 2 diabetes mellitus

    International Journal of Molecular Sciences, Vol. 16, Núm. 5, pp. 9469-9483

2014

  1. Bone turnover markers in patients with prostate carcinoma: Influence of sex steroids levels

    Journal of Bone and Mineral Metabolism, Vol. 32, Núm. 1, pp. 65-70

  2. Erratum to Bone turnover markers in patients with prostate carcinoma: influence of sex steroids levels [J Bone Miner Metab, DOI 10.1007/s00774-013-0466-5]

    Journal of Bone and Mineral Metabolism

  3. FGF23 in type 2 diabetic patients: Relationship with bone metabolism and vascular disease

    Diabetes Care

  4. Relationship of Dickkopf1 (DKK1) with Cardiovascular Disease and Bone Metabolism in Caucasian Type 2 Diabetes Mellitus

    PLoS ONE, Vol. 9, Núm. 11

2013

  1. Atherosclerotic disease in type 2 diabetes is associated with an increase in sclerostin levels

    Diabetes Care, Vol. 36, Núm. 6, pp. 1667-1674

  2. Ischemic heart disease is associated with vertebral fractures in patients with type 2 diabetes mellitus

    Journal of Diabetes Investigation, Vol. 4, Núm. 3, pp. 310-315

  3. Serum levels of bone resorption markers are decreased in patients with type 2 diabetes

    Acta Diabetologica, Vol. 50, Núm. 1, pp. 47-52

  4. Serum osteoprotegerin: Bone or cardiovascular marker in Type 2 diabetes males?

    Journal of Endocrinological Investigation, Vol. 36, Núm. 1, pp. 16-20

2012

  1. Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus

    Journal of Clinical Endocrinology and Metabolism, Vol. 97, Núm. 1, pp. 234-241

  2. Enfermedad cardiovascular, osteoporosis y riesgo de fractura

    Revista Clinica Espanola, Vol. 212, Núm. 4, pp. 188-192

  3. Fe de errores de "Guías de práctica clínica para la evaluación y tratamiento de la osteoporosis asociada a enfermedades endocrinas y nutricionales"

    Endocrinologia y Nutricion